ARTICLE | Clinical News
Glycopyrronium bromide regulatory update
May 9, 2016 7:00 AM UTC
EMA’s CHMP recommended against approval of Sialanar glycopyrronium bromide from Proveca to treat persistent drooling and excessive salivation in children and adolescents with neurological conditions. ...